EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Radiological assessment of body composition changes and complications in an era of incretin-based therapies: A narrative review

Jonah Moyal, Benjamin Rehany

University of Toronto Medical Journal · 11.05.2026 · 103 (2)

DOI: 10.33137/utmj.v103i2.46711 ↗

Kurz gefasst

Fachartikel in der Zeitschrift University of Toronto Medical Journal, online erschienen am 11.05.2026. Verfasst von Jonah Moyal und 1 weiteren Autor:innen. Die Arbeit nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Obesity and type 2 diabetes mellitus management have been transformed by the emergence of incretin-based therapies, such as dipeptidyl peptidase-4 inhibitors and glucagon-like peptide-1 receptor agonists. While these agents facilitate significant weight loss, traditional metrics like body mass index fail to distinguish between the loss of metabolically active visceral fat and the potentially detrimental depletion of lean body mass. This review examines the role of radiology in monitoring the physiological transformations induced by these medications.

Methods

This narrative review involved a comprehensive search across University of Toronto Library, PubMed, and Google Scholar to investigate the radiological manifestations and complications of incretin therapy. From an initial 210 records, 34 research studies were included after screening for key themes in body composition, gastrointestinal safety, and imaging modalities, including computed tomography, magnetic resonance imaging, and ultrasound.

Results

The analysis focuses on imaging-based evidence regarding changes in subcutaneous and visceral adipose tissue, alongside the preservation of skeletal muscle integrity. Radiological measurements can fill an unmet need to monitor metabolic health and body composition changes in individuals who require pharmacological intervention. Furthermore, this review identifies imaging markers for treatment-related complications and perioperative applicability.

Conclusion

Ultimately, this review advocates for a shift from weight-centric to composition-centric management. By integrating computed tomography, magnetic resonance imaging, and ultrasound into clinical workflows, clinicians can objectively quantify tissue quality and distribution. This holistic approach, combining pharmacological intervention with precision imaging and structured nutritional support, ensures that pharmacologically induced weight loss optimizes long-term functional health and patient safety.

Zitieren

APA

Moyal, J., & Rehany, B. (2026). Radiological assessment of body composition changes and complications in an era of incretin-based therapies: A narrative review. University of Toronto Medical Journal, 103(2). https://doi.org/10.33137/utmj.v103i2.46711

Vancouver

Moyal J, Rehany B. Radiological assessment of body composition changes and complications in an era of incretin-based therapies: A narrative review. University of Toronto Medical Journal. 2026;103(2). doi:10.33137/utmj.v103i2.46711

BibTeX
@article{Moyal2026,
  author = {Moyal, Jonah and Rehany, Benjamin},
  title = {Radiological assessment of body composition changes and complications in an era of incretin-based therapies: A narrative review},
  journal = {University of Toronto Medical Journal},
  year = {2026},
  volume = {103},
  number = {2},
  doi = {10.33137/utmj.v103i2.46711}
}
Kostenlos starten →